Ulipristal Acetate Patent Expiration
Ulipristal Acetate is Used for emergency contraception within 120 hours after unprotected intercourse, particularly effective in overweight women. It was first introduced by Laboratoire Hra Pharma
Ulipristal Acetate Patents
Given below is the list of patents protecting Ulipristal Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ella | US8426392 | Method for providing emergency contraception | Jun 12, 2030 | Lab Hra Pharma |
| Ella | US8962603 | Method for post coital contraception in overweight or obese female subjects using ulipristal acetate | Jun 12, 2030 | Lab Hra Pharma |
| Ella | US8512745 | Ulipristal acetate tablets | Jun 02, 2030 | Lab Hra Pharma |
| Ella | US10159681 | Method for on-demand contraception | Apr 13, 2030 | Lab Hra Pharma |
| Ella | US10772897 | Method for on-demand contraception | Apr 13, 2030 | Lab Hra Pharma |
| Ella | US9283233 | Method for on-demand contraception | Apr 13, 2030 | Lab Hra Pharma |
| Ella | US8735380 | Ulipristal acetate tablets | Feb 20, 2029 | Lab Hra Pharma |
| Ella | US9844510 | Ulipristal acetate tablets | Dec 08, 2028 | Lab Hra Pharma |
Ulipristal Acetate's Family Patents
Explore Our Curated Drug Screens
Ulipristal Acetate Generic API Manufacturers
Only one generic application has been filed for Ulipristal Acetate.
Given below is the list of companies who have filed for Ulipristal Acetate generic, along with the locations of their manufacturing plants worldwide.
1. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Ulipristal Acetate. This 30mg version comes by the name LOGILIA. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet | Prescription | ORAL | AB | Feb 13, 2017 |